SPOTLIGHT -
Slideshow
Author(s):
Which of these agents best prevents relapse? A recent study employed a novel approach to find out.
Phase 3 Development Plan for Evenamide as Add-On Therapy for Treatment-Resistant Schizophrenia
Here's to a Psychedelic Revolution
The Dawn of a New Era for Schizophrenia
Treating ‘Morally Objectionable’ Patients
Deprescribing: Does the Term Belong in the Psychiatric Lexicon?
April in Review: Updates on the Psychiatric Treatment Pipeline